# Special Issue “Targeting of Functional Proteins in Disease Therapeutics: Enzyme Function and Inhibition Studies”

**Authors:** Sung-Kun Kim

PMC · DOI: 10.3390/ijms27010070 · International Journal of Molecular Sciences · 2025-12-21

## Full-text entities

- **Genes:** ASGR1 (asialoglycoprotein receptor 1) [NCBI Gene 432] {aka ASGPR, ASGPR1, CLEC4H1, HL-1}
- **Diseases:** obesity (MESH:D009765), genetic disorders (MESH:D030342), metabolic disease (MESH:D008659), neurodegeneration (MESH:D019636), injury to (MESH:D014947), inflammatory (MESH:D007249), liver disease (MESH:D008107), cancer (MESH:D009369), hypercholesterolemia (MESH:D006937), infectious disease (MESH:D003141), atherosclerosis (MESH:D050197), toxicity (MESH:D064420), infections (MESH:D007239)
- **Chemicals:** NAD(H) (MESH:D009243)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786029/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786029/full.md

---
Source: https://tomesphere.com/paper/PMC12786029